Feifei Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- RNA Research and Splicing
- Microbial Metabolic Engineering and Bioproduction
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
Papers in
-
- Genomics and Chromatin Dynamics 9
- Bone Metabolism and Diseases 7
- RNA modifications and cancer 7
- RNA Research and Splicing 5
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 7
- Co-authors
- Changqi Zhao (3 shared papers)Lili Wang (3 shared papers)Na Zhang (1 shared paper)Qiping Zheng (4 shared papers)Zhihua Zhang (8 shared papers)Liancheng Zhu (9 shared papers)Ying‐Jin Yuan (2 shared papers)Jianjun Qiao (2 shared papers)
- Journals
- Clinical & Experimental Immunology (4 papers)Frontiers in Microbiology (2 papers)Metabolic Engineering (2 papers)Bioinformatics (2 papers)International Journal of Oncology (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Feifei Li
116 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 390
- Molecular Biology 1.3k
- Geriatrics and Gerontology 48
- Rheumatology 144
- Pharmacology 77
Countries citing papers authored by Feifei Li
This map shows the geographic impact of Feifei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Li more than expected).
Fields of papers citing papers by Feifei Li
This network shows the impact of papers produced by Feifei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Li. The network helps show where Feifei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 112 | |
| 2 | 2018 | 104 | |
| 3 | 2019 | 94 | |
| 4 | 2015 | 84 | |
| 5 | 2014 | 71 | |
| 6 | 2018 | 66 | |
| 7 | 2011 | 63 | |
| 8 | 2011 | 61 | |
| 9 | 2013 | 60 | |
| 10 | 2017 | 56 | |
| 11 | 2016 | 53 | |
| 12 | 2013 | 49 | |
| 13 | 2009 | 49 | |
| 14 | 2018 | 48 | |
| 15 | 2015 | 44 | |
| 16 | 2022 | 42 | |
| 17 | 2022 | 41 | |
| 18 | 2021 | 37 | |
| 19 | 2022 | 35 | |
| 20 | 2018 | 34 |
About Feifei Li
Feifei Li is a scholar working on Molecular Biology, Cancer Research, Rheumatology, Immunology and Pulmonary and Respiratory Medicine, having authored 122 papers that have together received 2.3k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (9 papers), MicroRNA in disease regulation (8 papers), Osteoarthritis Treatment and Mechanisms (7 papers), Bone Metabolism and Diseases (7 papers), Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (7 papers), RNA Research and Splicing (5 papers) and Sirtuins and Resveratrol in Medicine (5 papers). The work is most often cited by research in Cancer Research (390 citations), Molecular Biology (1.3k citations), Geriatrics and Gerontology (48 citations), Rheumatology (144 citations) and Pharmacology (77 citations). Feifei Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Changqi Zhao, Lili Wang, Na Zhang, Qiping Zheng, Zhihua Zhang, Liancheng Zhu, Ying‐Jin Yuan, Jianjun Qiao, Changyou Gao and Lie Ma. Their work appears in journals such as Clinical & Experimental Immunology, Frontiers in Microbiology, Metabolic Engineering, Bioinformatics and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.